LRRK2 and Parkinson disease: iPD patient-derived fibroblasts display mitochondrial fragmentation that is reversed by LRRK2 inhibition [139], and mitochondrial connectivity is reduced in G2019S LRRK2 PD fibroblast cultures [140].